Molly Purser, PhD, is an Associate Director of Health Economics in Regenerative Medicine and Advanced Therapies at RTI-HS. Dr. Purser is experienced in developing economic models to demonstrate the value of drugs and other health technologies and, in particular, models of cell therapies, gene therapies, and tissue-engineered products. She has substantial experience developing early-phase decision-making tools as well as later-phase launch models for use by health technology appraisal organizations. Prior to joining RTI- HS, she worked as a postdoctoral scholar at North Carolina State University in collaboration with the Wake Forest Institute for Regenerative Medicine. Her research experience includes oncology, rare diseases, medical devices, dermatology, pain, and genetic disorders. She is a member of the International Society of Pharmacoeconomics and Outcomes Research and has presented her research at a number of professional conferences. Dr. Purser’s work has been published in peer-reviewed journals including Advances in Therapy, Cellular Reprogramming, Pharmacoeconomics, Annals of Biomedical Engineering, and Annals of Thoracic Surgery.